Global

OPINION: Despite problems, America's vaccine rollout has been among the best in the world

Sun, 2021-02-21 12:52 — mike kraft

America's vaccine rollout has been among the best in the world It hasn't been perfect. It could be a whole lot worse. Dave Lawler Axios

America’s much-maligned vaccine rollout is actually going relatively well, at least compared to other wealthy countries.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about OPINION: Despite problems, America's vaccine rollout has been among the best in the world
Log in or register to post comments

Study indicates a Third of COVID survivors have long term symptoms

Sat, 2021-02-20 20:37 — mike kraft

A Third of COVID Survivors Have Long-Haul Symptoms Months after illness clears, many say symptoms like fatigue, loss of smell or taste and "brain fog" persist. WebMD

(HealthDay News) -- Many patients with mild to moderate COVID-19 could become "long haulers," suffering symptoms months after they clear their non-life-threatening infection, new research shows.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Study indicates a Third of COVID survivors have long term symptoms
1 comment
Log in or register to post comments

Coronavirus variants are like 'tidal waves' once they fully arrive

Sat, 2021-02-20 15:10 — mike kraft

Coronavirus variants are like 'tidal waves' once they fully arrive Although the U.S. finally reached an important milestone in the number of vaccinations surpassing the number of COVID-19 cases, the country is not out of the woods yet. YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Coronavirus variants are like 'tidal waves' once they fully arrive
Log in or register to post comments

Studies suggest that persons who had Covid should get single vaccine does

Sat, 2021-02-20 13:00 — mike kraft

Nearly 30 million people in the United States — and probably many others whose illnesses were never diagnosed — have been infected with the coronavirus so far. Should these people still be vaccinated?

Two new studies answer that question with an emphatic yes.

In fact, the research suggests that for these people just one dose of the vaccine is enough to turbocharge their antibodies and destroy the coronavirus — and even some more infectious variants.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Studies suggest that persons who had Covid should get single vaccine does
Log in or register to post comments

ANALYSIS: Most vaccine clinical trials fail to report data on participants’ ethnicity or race

Fri, 2021-02-19 12:33 — mike kraft

Most vaccine trials fail to report data on participant ethnicity or race - STAT Of the 230 trials researchers examined, more than 40% did not record participants’ race and about 65% did not report their ethnicity. Nicholas St. Fleur STAT

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about ANALYSIS: Most vaccine clinical trials fail to report data on participants’ ethnicity or race
Log in or register to post comments

Africa reaches 100,000 known COVID-19 deaths despite earlier low rates

Fri, 2021-02-19 11:23 — mike kraft

Africa reaches 100,000 known COVID-19 deaths as danger grows NAIROBI, Kenya (AP) — Africa has surpassed 100,000 confirmed deaths from COVID-19 as the continent praised for its early response to the pandemic now struggles with a dangerous resurgence and... AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Africa reaches 100,000 known COVID-19 deaths despite earlier low rates
Log in or register to post comments

How scarcity of niche biotech ingredients has slowed Covid-19 vaccine production

Fri, 2021-02-19 11:03 — mike kraft

Why grandparents can’t find vaccines: Scarcity of niche biotech ingredients Limited supply of key ingredients called lipids has constrained coronavirus vaccine manufacturing and contributed to the frustratingly slow rollout of shots in the United States and Europe. Christopher Rowland Washington Post

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about How scarcity of niche biotech ingredients has slowed Covid-19 vaccine production
Log in or register to post comments

Vaccine Developments: Pfizer seeks approval for storage at higher temperatures, J&J seeks WHO approval

Fri, 2021-02-19 10:49 — mike kraft

Pfizer seeks U.S. approval for COVID-19 vaccine to be stored at higher temperatures Pfizer Inc and BioNTech SE have asked the U.S. health regulator to relax requirements for their COVID-19 vaccine to be stored at ultra-low temperatures, potentially allowing for it to be kept in pharmacy freezers, they said on Friday. Reuters Staff U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

France establishes citizens' panel to counter vaccine antipathy

Thu, 2021-02-18 19:59 — mike kraft

Vaccine-wary France turns to citizens’ panel to boost trust in COVID-19 shots Panel advice on vaccines could counteract legacy of mistrust from past health scandals Science | AAAS

All across Europe, coronavirus vaccines are in scarce supply. But in France, they are also surprisingly unwanted: Recent polls suggest just 57% of the country intends to get vaccinated, whereas in the United Kingdom, 89% wants to get a shot for COVID-19.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?: